Posted On: 10/08/2015 1:12:26 AM
Post# of 72447
Anyone remember where the "Global trial" for Brilacidin was mentioned? That might bring these old Pfizer connections into play.
"Dr. Jorgensen has had an accomplished career at both large pharmaceutical and earlier stage biotechnology companies. He has held senior leadership positions in the Global Research and Development Division at Pfizer, Inc. Most notably, Dr. Jorgensen led the Zmax single-dose azithromycin clinical development program, the dalbavancin (second generation glycolipopeptide) medical development team, and Pfizer's first vaccine development group. Prior to joining PolyMedix, he served as Vice President, Clinical Research at AMAG Pharmaceuticals, where he oversaw ten global clinical trials across multiple medical areas"
"Dr. Jorgensen has had an accomplished career at both large pharmaceutical and earlier stage biotechnology companies. He has held senior leadership positions in the Global Research and Development Division at Pfizer, Inc. Most notably, Dr. Jorgensen led the Zmax single-dose azithromycin clinical development program, the dalbavancin (second generation glycolipopeptide) medical development team, and Pfizer's first vaccine development group. Prior to joining PolyMedix, he served as Vice President, Clinical Research at AMAG Pharmaceuticals, where he oversaw ten global clinical trials across multiple medical areas"
(0)
(0)
